GEOVAX LABS GOVX 深 沪
已收盘 12-19 16:00:00 美东时间
0.1592
-0.081
-33.69%
华盛通- 最 高0.2528
- 今 开0.2528
- 成交量 3249.22万股
- 最 低 0.1151
- 昨 收 0.2401
- 总市值 769.76万
- 52周最高 2.75
- 市盈率 静 --
- 换手率 0.07%
- 52周最低 0.1151
- 委 比 94.17%
- 总股本 4835.15万
- 历史最高 130.65
- 量 比 18.67
- 振 幅 57.35%
- 历史最低 0.1151
- 每 手 1
- 风险率 0.57%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多GeoVax Labs Files Prospectus For Best-Efforts Offering Of 18,292,683 Units And Pre-Funded Units With Warrants
GEOVAX LABS, INC. 18,292,683 Common UnitsEach Common Unit Consisting ofOne Share of Common Stock andTwo Warrants to Purchase One Share of Common Stock 18,292,683 Pre-Funded UnitsEach Pre-Funded Unit
12-13 06:42
美股大行评级 | 高盛上调百度、美敦力、晶科能源等多只个股目标价；家得宝遭9家机构下调目标价；
今日重点评级关注：富国银行：维持Annexon"超配"评级，目标价从14美元升至27美元；瑞穗：上调Relmada Therapeutics评级至"跑赢大市"，目标价从1美元升至10美元
11-20 10:28
D. Boral Capital Maintains Buy on Geovax Labs, Lowers Price Target to $6
D. Boral Capital analyst Jason Kolbert maintains Geovax Labs (NASDAQ:GOVX) with a Buy and lowers the price target from $9 to $6.
11-19 21:12
GeoVax outlines expedited GEO-MVA clinical trial and global partnership strategy for 2025-2026
Earnings Call Insights: GeoVax Labs (GOVX) Q3 2025 Management View David Dodd, Chairman, President & CEO, stated that "We remain confident in the continued progress and compelling outlook for our port...
11-14 11:42
Geovax Labs Q3 EPS $(0.31) Misses $(0.25) Estimate
Geovax Labs (NASDAQ:GOVX) reported quarterly losses of $(0.31) per share which missed the analyst consensus estimate of $(0.25) by 24 percent. This is a 65.93 percent increase over losses of $(0.91) per share from the
11-14 05:07
美股大行评级 | 潜在涨幅485.44%！Allarity Therapeutics获机构升目标价至9.25美元，维持"买入"评级
今日重点评级关注：Ascendiant Capital：维持Allarity Therapeutics"买入"评级，目标价从9美元升至9.25美元；JMP证券：维持Crinetics Pharmaceuticals"跑赢大市"评级，目标价从86美元升至143美元
09-29 09:15
D. Boral Capital Maintains Buy on Geovax Labs, Maintains $9 Price Target
D. Boral Capital analyst Jason Kolbert maintains Geovax Labs (NASDAQ: GOVX) with a Buy and maintains $9 price target.
09-26 19:25
Shares of vaccine companies are trading lower following a Daily Beast report suggesting that President Trump and Health and Human Services Robert F. Kennedy, Jr. will ban Covid-19 vaccines "within months." Also, a report suggested that a Covid-19 vaccine skeptic will lead the Covid-19 immunization task force.
Shares of vaccine companies are trading lower following a Daily Beast report su...
08-26 01:50
GeoVax Labs Receives Nasdaq Deficiency Letter
GeoVax Labs ( ($GOVX) ) has provided an announcement. On July 31, 2025, GeoVax ...
08-02 05:01
D. Boral Capital Maintains Buy on Geovax Labs, Maintains $9 Price Target
D. Boral Capital analyst Jason Kolbert maintains Geovax Labs (NASDAQ:GOVX) with a Buy and maintains $9 price target.
07-29 21:14
